Q 601
Alternative Names: Q-601Latest Information Update: 28 Apr 2024
At a glance
- Originator Qurient Co
- Class COVID-19 vaccines; Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported COVID 2019 infections; Influenza virus infections
Most Recent Events
- 28 Apr 2024 No recent reports of development identified for preclinical development in Influenza-virus-infections(Prevention) in South Korea (PO)
- 28 Apr 2024 No recent reports of development identified for research development in COVID-2019-infections(Prevention) in South Korea (PO)
- 23 Mar 2020 Q 601 is available for licensing as of 23 Mar 2020. www.qurient.com